Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
12/2006
12/21/2006WO2006133962A1 Side-chain extended ligation
12/21/2006WO2006133560A1 Psp94 diagnostic reagents and assays
12/21/2006WO2006105519A3 Protein microarray system
12/21/2006WO2006101441A3 Method for protein purification comprising heat incubation in acetic acidic solution
12/21/2006WO2006084130A3 Ultra-sensitive detection systems using multidimension signals
12/21/2006WO2006076025A3 Immune cell biosensors and methods of using same
12/21/2006WO2004066828A3 Apparatus for endoscopic surgical procedures
12/21/2006WO2004041172A3 Interferon antagonists useful for the treatment of interferon related diseases
12/21/2006US20060287508 Methods for stabilizing proteins
12/21/2006US20060287504 Universal procedure for refolding recombinant proteins
12/21/2006US20060287432 Peptide purification by means of metal ion affinity chromatography
12/21/2006US20060287250 Intermediates: omega(1-haloalkoxycarbonylamino)alkanoates, e.g., Benzyl 1-{[(1-Chloroethoxy)carbonyl]aminomethyl}-1-Cyclohexane Acetate
12/21/2006US20060287240 Method of stimulating prosaposin receptor activity
12/21/2006US20060287223 Remodeling and glycoconjugation of peptides
12/21/2006US20060286633 Methods for production of proteins
12/21/2006US20060286603 Combinatorial libraries of monomer domains
12/21/2006US20060286599 Open channel solid phase extraction systems and methods
12/21/2006US20060286069 G-CSF Conjugates
12/21/2006US20060286068 Polypeptides exhibiting granulocyte colony-stimulating factor (G-CSF) activity; conjugates between the polypeptides and a non-polypeptide moiety (PEG); for treatment of neutropenia or leukopenia; low in vitro bioactivity, long in vivo half-life, reduced receptor-mediated clearance
12/21/2006CA2612274A1 Side-chain extended ligation
12/21/2006CA2611048A1 Psp94 diagnostic reagents and assays
12/20/2006EP1734121A2 Genetically engineered human-derived Kunitz domains that inhibit human neutrophil elastase
12/20/2006EP1734047A1 Use of ionic liquids for protein extraction
12/20/2006EP1733039A2 Improved bacterial host cell for the direct expression of peptides
12/20/2006EP1732942A2 Synthetic chemokines, methods of manufacture, and uses
12/20/2006EP1732880A1 Assays for amphetamine and methamphetamine
12/20/2006EP1732587A2 Methods of protein fractionation using high performance tangential flow filtration
12/20/2006EP1732576A1 Method for the photostabilisation of phycobiliproteins in an aqueous extract, compositions containing stabilised phycobiliproteins and use of stabilised phycobiliproteins
12/20/2006EP1687421A4 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom
12/20/2006CN1882685A A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom
12/20/2006CN1882355A Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin
12/20/2006CN1880334A High purity albumin production process
12/20/2006CN1880333A Lysine fermented liquor tropina separation method
12/20/2006CN1880329A Reversible packaging micro fluent chip for separating and purifying biological sample
12/20/2006CN1291013C Method for preparing liver hydrogen peroxidase
12/20/2006CN1290863C Preparation and use of antioxidant component from protein liquid of living scorpion
12/20/2006CN1290857C Method for extracting and purifying microcytis toxin
12/19/2006US7151172 virion infectivity factor (vif) proteins; use in vaccine against the HIV-1 virus
12/19/2006US7151167 Open channel solid phase extraction systems and methods
12/19/2006US7151162 Capable of interacting with wnt-signalling pathway (beta-catenins and T-cell factors); cancer diagnosis
12/19/2006US7151159 Amino acid sequences for therapeutic and prophylactic use against diseases due to clostridium difficile toxins
12/19/2006US7151082 Administering an effective amount of an antagonist or inhibitor of high mobility group 1 protein (HMG1) for therapy of condition characterized by activation of the inflammatory cytokine cascade
12/19/2006US7150978 Transcription/translation; high throughput screening; genomics; proteomics
12/19/2006US7150973 Methods and kits for purifying his-tagged proteins
12/19/2006US7150971 Membrane-resident steroid receptors and methods of use thereof
12/19/2006US7150966 Determining whether fluorescently labeled compound is phosphorylated via monitoring/measuring shift in polarized fluorescence
12/19/2006US7150869 Gene therapy; cytokine complex; anticancer agent
12/14/2006WO2006132553A1 Preparation of metal ion-lactoferrin
12/14/2006WO2006132335A1 Fluorescent amino acid derivative
12/14/2006WO2006132293A1 Food composition having immunosuppressive effect by coating antigen structure of allergenic protein by polysaccharide modification
12/14/2006WO2006132050A1 Method for producing zinc oxide-protein complex
12/14/2006WO2006131687A1 Repeatable protein arrays
12/14/2006WO2006131550A1 Process for the purification of il-18 binding protein
12/14/2006WO2006089422A8 Protein and its use in diagnosing alzheimer's disease
12/14/2006WO2006017355A3 Improved aprotinin variants
12/14/2006WO2005079390A3 Inhibition of fgf signaling
12/14/2006WO2004108069A3 Compositions and methods for promoting neuronal outgrowth
12/14/2006WO2004101751A3 A modified rubisco large subunit ∈n-methyltransferase useful for targeting molecules to the active-site vicinity of ribulose-1, 5-bisphosphate
12/14/2006WO2004006861A3 Peptides and methods of screening immunogenic peptide vaccines against alzheimer's disease
12/14/2006US20060281906 Immobilized metal affinity chromatography using a support charged with zinc or cobalt and an imidazole binding buffer to separate fluorescently labelled his-tagged antibodies from heme proteins; high throughput assays
12/14/2006US20060281904 Colur reduction in canola protein isolate
12/14/2006US20060281685 biodrug as antitumor agents; hormone sensitive tumors; therapy for prostate gland or breast cancer
12/14/2006DE102005027172A1 Extraction of proteins, protein fragments or peptides from biological samples comprises using an ionic liquid as the extractant
12/14/2006CA2610804A1 Process for the purification of il-18 binding protein
12/13/2006EP1731528A1 Process for producing solubilized keratin
12/13/2006EP1731174A2 Polypeptides having a covalently bound N-terminal polyethylene glycol via hydrazone or oxime bond
12/13/2006EP1730166A2 Process for preparing macrocyclic dipeptides which are suitable for the treatment of hepatitis c viral infections
12/13/2006EP1729867A1 A method for chromatographic purification
12/13/2006EP1478382B1 Method for producing a powder inhalant containing a salt of the cgrp antagonist bibn4096
12/13/2006EP1434790B1 Calcium-influx inhibitory factor and method of isolation thereof
12/13/2006EP1329462B1 Method of producing human serum albumin involving heating step
12/13/2006EP1007969A4 Lithographic mask design and synthesis of diverse probes on a substrate
12/13/2006EP0760602B1 Use of fas ligand to suppress lymphocyte-mediated immune responses
12/13/2006CN1879051A Translating bifocal wear modality
12/13/2006CN1876817A Production method for human tumor necrosis factor TNF-alpha mutant
12/13/2006CN1876811A Preparation method of recombinant human alpha interferon
12/13/2006CN1876677A Novel lhrh antagonists, preparation method and pharmaceutical use thereof
12/13/2006CN1876676A Antineoplastic oligopeptide and its preparation method and application
12/13/2006CN1876675A Polyacrylamide gel electrophoresis method for wheat low molecular weight glutenin subunit
12/13/2006CN1876674A Natural preservative industrialized purification process
12/13/2006CN1876673A Method for separating protein adopting superparamagnetism silicon nanometer granule static adsorption
12/13/2006CN1289666C Process for separation and purification of gene recombinant protein heme oxygenase
12/13/2006CN1289659C High temperature neutral protenase strains, high temperature neutral proleinase and process thereof
12/13/2006CN1289526C Stem cell factor
12/12/2006US7148347 Reacting macrocyclic amide compound with hydroxy naphthalene or hydroxy quinoline derivative in a polar non-protic organic solvent in the presence of an organic or inorganic base
12/12/2006US7148334 Composition for protecting proteins degradation comprising small heat shock proteins (sHSPs) and method of two-dimensional gel electrophoresis using the sHSPs
12/12/2006US7148327 Reacting a keratin source with oxidative sulfitolysis to produce solids comprising reaction product in digestion liquor, separating the solids from the digestion liquor, extracting the solids with a composition consisting of water or water and surfactant and separating extract from solids, recovering
12/12/2006US7148324 Compositions and methods for enhancement of major histocompatibility complex class I restricted antigen presentation
12/12/2006US7148322 Process for the preparation of echinocandin derivatives
12/12/2006US7148195 Antitumor agents; hormone sensitive tumors; therapy for prostate gland or breast cancer
12/12/2006US7148050 method of screening for agents which decrease extracellular matrix degradation; test compound which binds to the proteine kinase-like protein polypeptide is thereby identified as a potential agent for decreasing extracellular matrix degradation
12/12/2006US7148047 Genetically engineered microorganism for use in the biosynthesis of cysteine
12/12/2006US7148001 In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of Alzheimer's and Prion diseases
12/12/2006US7147912 Amphipathic proteinaceous coating on nanoporous polymer
12/12/2006US7147856 Stable radioiodine conjugates and methods of their synthesis
12/12/2006US7147762 Separation of protein and/or peptide components of a sample in a convection stabilised medium. More specifically, the method comprises the steps to contact the sample with the separation medium; to apply a voltage across said medium; and to observe
12/12/2006CA2264630C Shear separation method and system
12/12/2006CA2207723C Method for removing n-terminal methionine
12/12/2006CA2189659C Production of biologically active recombinant neurotrophic protein
12/12/2006CA2129045C Process for recovering a high-purity virus-inactivated factor viii by anion exchanger chromatography